XML 83 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
Shareholders' Deficit - Narrative (Details) - USD ($)
shares in Millions
12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Approved share repurchase program $ 600,000,000    
Remaining authorized stock purchase plan $ 348,000,000    
Stock Award      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 1.3 0.6 0.9
Antidilutive securities excluded from calculation of earnings per share $ 100,000    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Proceeds from stock options exercised 400,000    
Tax benefit from exercise of stock options 100,000    
Stock-based compensation expense related to non-vested awards $ 5,200,000    
Weighted average period to recognize remaining expense over 1 year 10 months 24 days    
Time- Based Stock Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense related to non-vested awards $ 8,700,000    
Weighted average period to recognize remaining expense over 1 year 8 months 12 days    
Performance- Based Stock Awards      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation expense related to non-vested awards $ 7,800,000    
Weighted average period to recognize remaining expense over 2 years 1 month 6 days